Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)

SHE:301258 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	3,094	2,153	2,959	3,598	-	-
Market Cap Growth	48.09%	-27.24%	-17.76%	-	-	-
Enterprise Value	1,762	771	1,545	2,218	-	-
Last Close Price	34.50	23.55	31.47	37.70	-	-
PE Ratio	41.04	131.23	26.38	20.29	-	-
PS Ratio	7.04	5.01	6.05	6.33	-	-
PB Ratio	1.62	1.14	1.52	1.91	-	-
P/TBV Ratio	1.67	1.18	1.54	1.93	-	-
P/FCF Ratio	-	-	55.68	35.60	-	-
P/OCF Ratio	43.80	45.74	31.23	23.80	-	-
EV/Sales Ratio	4.01	1.80	3.16	3.90	-	-
EV/EBITDA Ratio	48.63	19.93	10.38	10.54	-	-
EV/EBIT Ratio	-	-	16.63	13.97	-	-
EV/FCF Ratio	-18.95	-	29.07	21.95	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.03	-
Debt / EBITDA Ratio	0.03	0.04	0.02	0.01	0.10	-
Debt / FCF Ratio	-	-	0.04	0.03	0.16	-
Net Debt / Equity Ratio	-0.70	-0.71	-0.73	-0.75	-0.45	-0.35
Net Debt / EBITDA Ratio	-37.42	-34.79	-9.52	-6.74	-1.83	-1.11
Net Debt / FCF Ratio	14.33	23.11	-26.66	-14.03	-2.82	-2.16
Asset Turnover	0.21	0.20	0.23	0.37	0.59	0.62
Inventory Turnover	2.63	2.23	2.15	3.29	4.88	3.86
Quick Ratio	7.83	9.98	13.23	10.13	2.56	2.70
Current Ratio	8.56	11.10	14.71	11.01	2.98	3.36
Return on Equity (ROE)	3.99%	0.86%	5.85%	13.49%	17.61%	23.42%
Return on Assets (ROA)	-0.18%	-0.27%	2.76%	6.47%	9.74%	13.21%
Return on Invested Capital (ROIC)	-0.92%	-1.54%	16.26%	31.73%	28.64%	36.14%
Return on Capital Employed (ROCE)	-0.30%	-0.50%	4.60%	8.10%	17.20%	24.00%
Earnings Yield	2.46%	0.76%	3.79%	4.93%	-	-
FCF Yield	-3.00%	-2.71%	1.80%	2.81%	-	-
Dividend Yield	0.26%	0.39%	1.91%	1.54%	-	-
Payout Ratio	10.88%	335.10%	47.39%	20.83%	0.36%	71.16%
Buyback Yield / Dilution	1.75%	0.88%	-6.83%	-25.31%	0.17%	-2.00%
Total Shareholder Return	2.02%	1.26%	-4.93%	-23.77%	0.17%	-2.00%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.